Viatris is a global healthcare company committed to empowering people worldwide to live healthier at every stage of life. The company was formed through the merger of Mylan and Upjohn, a division of Pfizer, and operates in over 165 countries and territories. Viatris offers a diverse portfolio of medicines across a broad range of therapeutic areas, including infectious diseases, oncology, and cardiovascular health.

Viatris is dedicated to sustainability and has implemented various initiatives to reduce its environmental impact. The company focuses on responsible sourcing, efficient resource use, and minimizing waste. Viatris has set targets to reduce greenhouse gas emissions and improve energy efficiency across its operations. Additionally, the company is committed to transparency and regularly publishes its progress in sustainability reports.

Viatris is actively working towards achieving sustainability certifications and accreditations to further validate its efforts. The company is also involved in community programs aimed at improving health outcomes and access to healthcare in underserved regions. However, detailed information on specific sustainability metrics and achievements is limited.